Additionally, while not found to be significant, RBΔCDK activation trended to reduce PD-L1 staining, suggesting that RB activation in the tumor compartment could potentially enhance the anti-tumor immune response by reducing immune exhaustion (Fig. 6E, F). This evidence concerns the gene RB1 and neoplasm.